Provided by Tiger Trade Technology Pte. Ltd.

BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS

359.23
-7.5000-2.05%
Volume:213.45K
Turnover:76.15M
Market Cap:40.95B
PE:64.27
High:359.42
Open:354.01
Low:352.86
Close:366.73
52wk High:385.22
52wk Low:253.95
Shares:114.00M
Float Shares:85.69M
Volume Ratio:0.79
T/O Rate:0.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.59
EPS(LYR):2.47
ROE:14.66%
ROA:7.46%
PB:7.92
PE(LYR):145.44

Loading ...

Goldman Sachs Competitor Adjusts BeOne Medicines Target Upward, Bullish Ratings Maintained

Deep News
·
Aug 09

BEONE MEDICINES Confirms External CMO Supply for Baiyueda, All Processes On Schedule

Deep News
·
Aug 07

BEONE MEDICINES: Approximately 95% of Pancreatic Cancer Cases Show KRAS Mutation, Around 20% Exhibit MTAP Deletion, Enabling Easy Identification of Overlapping Patient Groups

Deep News
·
Aug 07

BEONE MEDICINES Reports BRUKINSA Captures Over Half of New CLL/SLL Patient Share

Deep News
·
Aug 07

Beigene's GPC3x4-1BB Candidate Moves From Phase 1 to a Potential Pivotal Phase 2 Study in About 19 Months

Deep News
·
Aug 07

BEONE MEDICINES Halts Initial KRAS Inhibitor Project but Remains Active in RAS Field

Deep News
·
Aug 07

BEONE MEDICINES Plans to Unveil Preliminary CEA ADC Findings for Non-Small Cell Lung Cancer, Including Both Squamous and Non-Squamous Cases

Deep News
·
Aug 07

Movement Alert|BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS Rises 5.49% in Regular Trading, Q2 Earnings Significantly Beat Expectations as Multiple Institutions Raise Target Prices

Market Focus
·
Aug 07

Movement Alert|BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS Rises 5.48% in Pre-Market Trading, Q2 Earnings Significantly Beat Expectations as Multiple Institutions Raise Target Prices

Market Focus
·
Aug 07

Movement Alert|BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS Rises 5.16% Overnight, Q2 Earnings Beat Expectations as Multiple Institutions Raise Target Prices

Market Focus
·
Aug 07

CLSA Maintains Outperform Rating on BEONE MEDICINES, Raises Price Target to HK$321.70

Deep News
·
Aug 07

BEONE MEDICINES Surges Over 4% Intraday as UOB Kay Hian Raises Target Price to HK$265

Deep News
·
Aug 07

BeOne Medicines (ONC) Earnings Beat And Higher Guidance Leave Valuation In Focus

Simply Wall St.
·
Aug 07

Hong Kong Stock Moves: BEONE MEDICINES Surges Nearly 4% After Earnings, Adjusted Net Profit Up 111% YoY in First Half, Solid Tumor Progress Noted

Stock News
·
Aug 07

BeOne Medicines Shares Trading At Discount To Fair Value, RBC Says

MT Newswires Live
·
Aug 07

Beone Medicines : Leerink Partners Raises Target Price to $387 from $377

THOMSON REUTERS
·
Aug 06

Barclays Remains a Buy on BeOne Medicines (ONC)

TIPRANKS
·
Aug 06

Beone Medicines : TD Cowen Raises Target Price to $454 from $424

THOMSON REUTERS
·
Aug 06

Interim Net Profit Surges 627%, Full-Year Revenue Guidance Raised: Beone Medicines Rebounds on Hong Kong Exchange, Huabao's Innovative Drug ETF Sees Premium Trading

Deep News
·
Aug 06

Hong Kong Stock Exchange News Highlights: Beone Medicines Sees 111% Surge in Adjusted Net Profit for First Half of the Year

Stock News
·
Aug 06